Business

Johnson & Johnson profit falls 35% as coronavirus reduces sales of beauty products and medical devices

Johnson & Johnson Executive Committee Vice President Dr. Paul Stoffels talks about accelerating the development of the coronavirus vaccine and expanding distribution. Johnson & Johnson’s second-quarter earnings fell 35 percent from a year earlier as COVID-19 slowed demand for beauty products and medical devices. The New Brunswick, NJ-based healthcare product …

Read More »